PAHC Phibro Animal Health Corporation

34.08USD-4.19%Mkt Cap: 1.38B USDP/E: 13.58

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three…

Institutional holders20 on file

Key Statistics

Company
Market Cap1.38B USD
Enterprise Value2.15B USD
Revenue (TTM)1.54B USD
Gross Profit512.51M USD
Net Income (TTM)99.72M USD
Revenue/Share37.99 USD
Last Price34.08 USD
Fiscal Year EndJun 2026
MR QuarterSep 2026
Employees2.6K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)13.58
P/E (Forward)8.78
PEG1.68
EV/EBITDA8.72
EV/Revenue1.40
P/S0.90
P/B3.31
EPS (TTM)2.51 USD
EPS (Forward)3.88 USD
52W Range
28.2518% of range60.08
52W High60.08 USD
52W Low28.25 USD
Profitability
Gross Margin33.76%
Oper. Margin12.70%
EBITDA Margin16.00%
Profit Margin6.57%
ROE25.87%
ROA6.64%
ROIC12.92%
ROCE16.41%
Growth
Revenue Growth6.30%
Earnings Growth10.80%
Cash Flow & Leverage
Operating CF68.95M USD
CapEx (TTM)59.09M USD
FCF Margin-0.31%
FCF Yield-0.35%
Net Debt706.39M USD
Net Debt/EBITDA2.87
Net Debt/FCF—
Balance Sheet
Debt/Equity2.05
Current Ratio3.19
Quick Ratio1.04
Book Value/Sh10.29 USD
Cash/Share2.15 USD
Dividends
Fwd Div Rate0.48 USD
Trail. Div Rate0.48 USD
Div. Yield1.35%
5Y Avg Yield2.05%
Payout Ratio19.12%
Ex-Div DateNov 25, 2026
Pay DateDec 16, 2026
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)47.00 USD
Upside (mean)+37.9%
Target Range37.00 USD – 55.00 USD
37.00+37.9% to mean55.00
# Analysts3
Ownership
Shares Out.21.11M
Float20.91M
Insiders0.88%
Institutions107.66%
Short Interest
Short Ratio5.0d
Short % Float7.00%
Short % Out.2.51%
Shares Short1.02M
Short (prev mo.)1.02M
Technical
SMA 5036.68 (-7.1%)
SMA 20041.02 (-16.9%)
Beta0.40
S&P 52W Chg12.08%
Avg Vol (30d)204.46K
Avg Vol (10d)245.82K
Technical Indicators
RSI (14)40.3
MACD-0.7422
MACD Signal-0.5115
MACD Hist.-0.2307
BB Upper40.64 USD
BB Middle36.57 USD
BB Lower32.50 USD
BB Width22.24%
ATR (14)1.507 USD
Vol Ratio (20d)0.51x

About Phibro Animal Health (NASDAQ: PAHC)

›

Phibro Animal Health (NASDAQ: PAHC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2,605 employees.

The shares were at 34.08 USD on 19 November 2026, down 16.8% over 52 weeks. Its 52-week range is 28.25 USD to 60.08 USD: the price is 43.3% below the high and 20.6% above the low.

At a market capitalisation of 1.38B USD, it trades at 13.6 times trailing earnings and 8.8 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 45% for PAHC. It pays a dividend yielding 1.35% (it pays out 19% of its earnings), against a median of 1.90% among the dividend payers in that peer group.

Phibro Animal Health reports return on equity of 25.9%, an operating margin of 12.7% and revenue up 6.3% year over year.

Its debt exceeds its cash by 706.39M USD, a debt-to-equity ratio of 2.05. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 3 analysts cover the stock, with an average rating of Hold; their mean price target of 47.00 USD is 37.9% above the current price. The next earnings report is expected on 3 February 2027.